These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 5491454)

  • 1. Measles (rubeola) and rubella: (1) dangers of the layman's confusion (2) mass measles immunization.
    Pediatrics; 1970 Dec; 46(6):978-9. PubMed ID: 5491454
    [No Abstract]   [Full Text] [Related]  

  • 2. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide campaign for vaccination of adults against rubella and measles--Costa Rica, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):976-9. PubMed ID: 11724151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New points of view on measles and rubella vaccination].
    Vivell O
    Med Welt; 1972 Oct; 23(42):1486-8. PubMed ID: 4636872
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the measles-rubella mass vaccination campaign in the population covered by Tehran University of Medical Sciences.
    Majdzadeh R; Moradi A; Zeraati H; Sepanlou SG; Zamani G; Zonobi V
    East Mediterr Health J; 2008; 14(4):810-7. PubMed ID: 19166164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles-rubella mass immunization campaign in Albania, November 2000.
    Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A
    J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps.
    Ferson MJ; Robertson PW; Whybin LR
    Med J Aust; 1994 Apr; 160(8):478-82. PubMed ID: 8170422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The measles-mumps-rubella vaccination program in Finland.
    Lerman SJ
    N Engl J Med; 1995 Apr; 332(16):1103. PubMed ID: 7898541
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measles and rubella].
    Takayama N
    Rinsho Byori; 2005 Sep; 53(9):845-52. PubMed ID: 16235838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P
    Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
    [No Abstract]   [Full Text] [Related]  

  • 15. [Measles-rubella vaccination campaign].
    Infirm Fr; 1984 Jan; (251):23-6. PubMed ID: 6561159
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preventive vaccination against measles and rubella].
    Goetz O
    Med Klin; 1972 Feb; 67(7):217-21. PubMed ID: 5014396
    [No Abstract]   [Full Text] [Related]  

  • 17. [Elimination of measles and congenital rubella: what vaccination strategy for the future?].
    Gaudelus J
    Arch Pediatr; 2005 Dec; 12 Spec No 4():11-3. PubMed ID: 16456951
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles and rubella immunisation campaign. Safety untested.
    Stephenson R
    BMJ; 1994 Oct; 309(6962):1162. PubMed ID: 7987136
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran.
    Pourabbas B; Ziyaeyan M; Alborzi A; Mardaneh J
    Int J Infect Dis; 2008 Jan; 12(1):43-6. PubMed ID: 17950020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.